News

The collaborations include a drug discovery project with Western University; a co-development project with Delmar Chemicals; and a drug discovery project with a major global pharmaceutical company. Critical

The DVS Sciences CyTOF 2 system uses the same mass cytometry technology for the global adoption of the CyTOF Mass Cytometer. The technology enables comprehensive functional and phenotypic

Presented at the 2013 Annual Meeting of the International Anesthesia Research Society (IARS) in San Diego, US, the first study evaluated the use of Exparel administered through Infiltration

Built for the clinical and commercial manufacture of tablets and capsules, the 15,000 ft² facility in South Wales will enable Penn Pharma to improve on its heritage and

ZenRx will provide an upfront payment, milestones and royalties. Zenith Technology Corporation will commit a significant amount of resources to the Oraxol and Oratecan global development programs, providing

Tricast president and CEO Greg Rucinski said that the AccuCAST leapfrogs standard Big Data approaches to generate analysis of pharmacy benefits usage, cost and compliance all in real

Net revenues were $4.9bn for the first quarter of 2013 compared to $5.1bn for the first quarter of 2012. Teva president and chief executive officer Dr. Jeremy Levin

Nymox CEO Paul Averback said, "Final completion of enrollment in this last major pivotal U.S. study is an important milestone in the NX-1207 development pathway. We look forward

Nasal spray, oral spray and nasal swab delivery form products, which will be manufactured by Oasis Health, to offer relief and treatment of nausea. Itonis Pharmaceuticals founding member